Pharma Journalist -

Tmunity Therapeutics, in pursuit of its vision to save and improve lives by delivering the full potential of next-generation T-cell immunotherapy, closed a $75 million Series B…
Read More...

Dicerna Pharmaceuticals, Inc. announced a research collaboration and licensing agreement with Roche to develop novel therapies for the treatment of chronic hepatitis B virus (HBV)…
Read More...

Daiichi Sankyo Company, Limited and Sarah Cannon Research Institute (Sarah Cannon) announced that the first patient has been dosed in a first-in-human phase 1/2 study evaluating…
Read More...

NuChem Therapeutics, a drug discovery and development contract research organization (CRO) located in Montreal, specializing in synthetic and medicinal chemistry services, has just…
Read More...

AstraZeneca has agreed the sale and licence of the commercial rights to Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended release) in Europe…
Read More...

Novartis announced the United States Food & Drug Administration (FDA) placed a partial hold on clinical trials for intrathecal administration of AVXS-101. The announcement follows…
Read More...

Pandion Therapeutics and Astellas Pharma announced the signing of a License and Collaboration Agreement directed toward the research, development, and commercialization of locally…
Read More...

Biogen Inc. and Alkermes plc announced that the U.S. Food and Drug Administration (FDA) approved VUMERITY (diroximel fumarate), a novel oral fumarate with a distinct chemical structure,…
Read More...

Roche announced that the European Medicines Agency (EMA) has validated the company’s Marketing Authorisation Application (MAA) for satralizumab for the treatment of adult and adolescent…
Read More...

Pascal Biosciences Inc. and Y-Biologics announced a research collaboration agreement for the discovery and development of novel bispecific antibodies for the treatment of leukemia.…
Read More...